BIOMAT Database Logo BIOMAT Database Logo

Elevated preoperative CEA is associated with worse survival in stage I-III rectal cancer patients. 2012

I Tarantino, and R Warschkow, and M Worni, and K Merati-Kashani, and D Köberle, and B M Schmied, and S A Müller, and T Steffen, and T Cerny, and U Güller
Department of Surgery, Kantonsspital St Gallen, 9007 St Gallen, Switzerland. Tarantino@kssg.ch

BACKGROUND The objective of this investigation was to assess whether preoperative carcinoembryonic antigen (CEA) level is an independent predictor of overall survival in rectal cancer patients. METHODS All patients (n=504) undergoing a resection for stage I-III rectal cancer at the Kantonsspital St Gallen were included into a database between 1991 and 2008. The impact of preoperative CEA level on overall survival was assessed using risk-adjusted Cox proportional hazard regression models and propensity score methods. RESULTS In risk-adjusted Cox proportional hazard regression analyses, preoperative CEA level (hazard ratio (HR): 1.98, 95% confidence interval (CI): 1.36-2.90, P<0.001), distance from anal verge (<5 cm: HR: 1.93, 95% CI: 1.11-3.37; P=0.039), older age (HR: 1.07, 95% CI: 1.05-1.09; P<0.001), lower body mass index (HR: 0.94, 95% CI: 0.89-0.98; P=0.006), advanced tumour stage (stage II HR: 1.41, 95% CI: 0.85-2.32; stage III HR: 2.08, 95% CI: 1.31-3.31; P=0.004), R 1 resection (HR: 5.65, 95% CI: 1.59-20.1; P=0.005) and chronic kidney disease (HR: 2.28, 95% CI: 1.03-5.04; P=0.049) were all predictors for poor overall survival. CONCLUSIONS This is one of the first investigations based on a large cohort of exclusively rectal cancer patients demonstrating that preoperative CEA level is a strong predictor of decreased overall survival. Preoperative CEA should be used as a prognostic factor in the preoperative assessment of rectal cancer patients.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D012004 Rectal Neoplasms Tumors or cancer of the RECTUM. Cancer of Rectum,Rectal Cancer,Rectal Tumors,Cancer of the Rectum,Neoplasms, Rectal,Rectum Cancer,Rectum Neoplasms,Cancer, Rectal,Cancer, Rectum,Neoplasm, Rectal,Neoplasm, Rectum,Rectal Cancers,Rectal Neoplasm,Rectal Tumor,Rectum Cancers,Rectum Neoplasm,Tumor, Rectal
D012044 Regression Analysis Procedures for finding the mathematical function which best describes the relationship between a dependent variable and one or more independent variables. In linear regression (see LINEAR MODELS) the relationship is constrained to be a straight line and LEAST-SQUARES ANALYSIS is used to determine the best fit. In logistic regression (see LOGISTIC MODELS) the dependent variable is qualitative rather than continuously variable and LIKELIHOOD FUNCTIONS are used to find the best relationship. In multiple regression, the dependent variable is considered to depend on more than a single independent variable. Regression Diagnostics,Statistical Regression,Analysis, Regression,Analyses, Regression,Diagnostics, Regression,Regression Analyses,Regression, Statistical,Regressions, Statistical,Statistical Regressions
D002272 Carcinoembryonic Antigen A glycoprotein that is secreted into the luminal surface of the epithelia in the gastrointestinal tract. It is found in the feces and pancreaticobiliary secretions and is used to monitor the response to colon cancer treatment. Antigens, CD66e,CD66e Antigen,Antigen, CD66e,Antigen, Carcinoembryonic,CD66e Antigens
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

I Tarantino, and R Warschkow, and M Worni, and K Merati-Kashani, and D Köberle, and B M Schmied, and S A Müller, and T Steffen, and T Cerny, and U Güller
Elevated CEA is associated with worse survival in recurrent rectal cancer.
December 2017, Oncotarget,
I Tarantino, and R Warschkow, and M Worni, and K Merati-Kashani, and D Köberle, and B M Schmied, and S A Müller, and T Steffen, and T Cerny, and U Güller
Elevated preoperative CEA is associated with subclinical nodal involvement and worse survival in stage I non-small cell lung cancer: a systematic review and meta-analysis.
October 2020, Journal of cardiothoracic surgery,
I Tarantino, and R Warschkow, and M Worni, and K Merati-Kashani, and D Köberle, and B M Schmied, and S A Müller, and T Steffen, and T Cerny, and U Güller
Survival of patients with T3 stage III rectal cancer is significantly worse than T2 stage III rectal cancer. A new proposal of a subdivision of stage III rectal cancer.
January 2009, Digestive surgery,
I Tarantino, and R Warschkow, and M Worni, and K Merati-Kashani, and D Köberle, and B M Schmied, and S A Müller, and T Steffen, and T Cerny, and U Güller
Survival among clinical stage I-III rectal cancer patients treated with different preoperative treatments: A population-based comparison.
August 2016, Cancer epidemiology,
I Tarantino, and R Warschkow, and M Worni, and K Merati-Kashani, and D Köberle, and B M Schmied, and S A Müller, and T Steffen, and T Cerny, and U Güller
Elevated preoperative carcinoembryonic antigen (CEA) and Ki67 is predictor of decreased survival in IIA stage colon cancer.
January 2013, World journal of surgery,
I Tarantino, and R Warschkow, and M Worni, and K Merati-Kashani, and D Köberle, and B M Schmied, and S A Müller, and T Steffen, and T Cerny, and U Güller
Presence of bone marrow micro-metastases in stage I-III colon cancer patients is associated with worse disease-free and overall survival.
May 2017, Cancer medicine,
I Tarantino, and R Warschkow, and M Worni, and K Merati-Kashani, and D Köberle, and B M Schmied, and S A Müller, and T Steffen, and T Cerny, and U Güller
The Diet of Higher Insulinemic Potential Is Not Associated with Worse Survival in Patients with Stage III Colon Cancer (Alliance).
August 2020, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
I Tarantino, and R Warschkow, and M Worni, and K Merati-Kashani, and D Köberle, and B M Schmied, and S A Müller, and T Steffen, and T Cerny, and U Güller
Preoperative Chemoradiotherapy for Stage III Rectal Cancer.
November 2008, Gastrointestinal cancer research : GCR,
I Tarantino, and R Warschkow, and M Worni, and K Merati-Kashani, and D Köberle, and B M Schmied, and S A Müller, and T Steffen, and T Cerny, and U Güller
Preoperative hypoalbuminemia is associated with worse outcomes in colon cancer patients.
October 2017, Clinical nutrition (Edinburgh, Scotland),
I Tarantino, and R Warschkow, and M Worni, and K Merati-Kashani, and D Köberle, and B M Schmied, and S A Müller, and T Steffen, and T Cerny, and U Güller
Higher vitamin B6 status is associated with improved survival among patients with stage I-III colorectal cancer.
August 2022, The American journal of clinical nutrition,
Copied contents to your clipboard!